GSK enters agreement to acquire Nuvalent for $10.6 Billion
On Jun. 9, 2026, GSK announced that it has entered an agreement to acquire Nuvalent, a Boston-based clinical-stage…
-
-
Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billion
On Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with…
-
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics Worth Up to $2 Billion
On Jun. 3, 2026, Alnylam Pharmaceuticals, the leading RNAi therapeutics company, and Inceptive Nucleics, which builds foundation models…
-
CEPI funds next phase of nanoparticle vaccine platform to support rapid outbreak response
On Jun. 2, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced New funding will support the continued…
-
CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates
On May 31, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced it will urgently accelerate development of…
-
New MRI sensors developed at MIT sensitively detect target molecules in the brain and body.
On May 27, 2026, researchers at Massachusetts Institute of Technology announced that MRI can noninvasively capture detailed images…
-
European Union and Singapore Back CEPI’s Plan to Boost Global Defences Against Epidemic and Pandemic Threats
On May 18, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) welcomed landmark financial commitments from two of…
-
Roche agrees to acquire US-based PathAI for $1 Billion
On May 6, 2026, Swiss pharmaceutical giant Roche announced it had agreed to acquire U.S.-based digital pathology and…
-
Lilly to acquire Kelonia Therapeutics for $3.25 billion to advance in vivo CAR-T cell therapies
On Apr. 20, 2026, Eli Lilly and Kelonia Therapeutics, a clinical-stage biotechnology company pioneering in vivo gene delivery,…
-
Kailera nets $625M, biotech’s biggest-ever IPO
On Apr. 17, 2026, Kailera Therapeutics, a high-profile drug startup aiming to compete with Novo Nordisk and Eli…
-
Biogen to Acquire Apellis for $5.6 billion, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
-
PTAB sides with Broad Institute over University of California on patent priority for use of CRISPR in eukaryotic cells
On Mar. 26, 2026, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (USPTO and PTAB,…
-
Nia Therapeutics Receives FDA Breakthrough Device Designation for AI-Guided Brain Implant to Treat Memory Loss
On Mar. 18, 2026, Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device…
-
New Genetic Risk Score Better Predicts Diabetes, Obesity and Downstream Complications
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
-
Stanley Family Foundation renews commitment to accelerate psychiatric research at Broad Institute
On Mar. 12, 2026, the Stanley Family Foundation renewed its commitment to psychiatric research at the Broad Institute,…
-
Biotechnology | Diagnostics | Medical Device | Medicine | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Mass General Brigham Receives Transformative $50 Million Gift to Shape Future of Cancer Research
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
-
Researchers Develop New Way to Safely Insert Gene-Sized DNA Into the Genome
On Mar. 11, 2026, taking a step towards developing genetic therapies at scale, researchers from Mass General Brigham…
-
Lilly to acquire Orna Therapeutics to advance cell therapies for $2.4 billion in cash
On Feb. 9, 2026, Eli Lilly and Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in…
-
Dana-Farber Researchers Create Experimental AI-based Oncologist’s Assistant
On Jan. 20, 2026, Dana-Farber researchers announced developing an AI-based oncologist’s assistant that shows the potential for AI…
-
AI model built by Yale and Google team finds new way to treat cancer
On Jan. 13, 2026, collaborating with Google’s top artificial intelligence labs, a team of Yale researchers announced they…
-
Four Flu-Related Deaths Among Children in Boston
On Jan. 6, 2026, the Boston Public Health Commission (BPHC) is informing residents that flu has been associated…
-
US measles outbreak tops 2,000 known infections
On Dec. 29, 2025, measles cases nationwide have reached 2,012, the Centers for Disease Control and Prevention (CDC)…
-
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE’s M2PC
On Dec. 5, 2025, Ginkgo Bioworks announced it has been awarded by the Environmental Molecular Sciences Laboratory (EMSL)…
-
Noninvasive imaging could replace finger pricks for people with diabetes
On Dec. 3, 2025, Massachusetts Institute of Technology (MIT) engineers announced they can accurately measure blood glucose by…
-
Artificial Intelligence | Biology | Diagnostics | Disease | Medicine | Pharmaceutical | Therapeutics
MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
-
Doctors still outperform AI in clinical reasoning, study shows
On Nov. 24, 2025, a study published in the New England Journal of Medicine show that a test…
-
New AI model could speed rare disease diagnosis
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
-
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
-
MIT researchers invent new human brain model to enable disease research, drug discovery
On Nov. 5, 2025, MIT researchers announced they have developed a new 3D human brain tissue platform, the…
